title: Asthmatics able to step down from inhaled corticosteroid treatment without loss of asthma control have low serum eotaxin/CCL11.
authors.affiliation: Department of Respiratory Diseases, Arhus University Hospital, Denmark.
authors.forename: Hans Jürgen
authors.initials: HJ
authors.lastname: Hoffmann
authors.forename: Lars Peter
authors.initials: LP
authors.lastname: Nielsen
authors.forename: Henrik
authors.initials: H
authors.lastname: Harving
authors.forename: John H
authors.initials: JH
authors.lastname: Heinig
authors.forename: Ronald
authors.initials: R
authors.lastname: Dahl
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives; D000730:Androstadienes / Q000008:administration & dosage; D001249:Asthma / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D015415:Biomarkers / Q000097:blood*; D054413:Chemokine CCL11 / Q000097:blood*; D019742:Chemokines, CC / Q000097:blood; D016207:Cytokines / Q000097:blood; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D000068298:Fluticasone; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012129:Respiratory Function Tests; D000068299:Salmeterol Xinafoate; D012720:Severity of Illness Index; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000730:Androstadienes; D015415:Biomarkers; D054413:Chemokine CCL11; D019742:Chemokines, CC; D016207:Cytokines; D003692:Delayed-Action Preparations; D000068299:Salmeterol Xinafoate; D000068298:Fluticasone; D000420:Albuterol